2010.08.05 Weekly Broadcast Email
There following updates were made to the CCCWFU CCOP Research Base website for the week of August 2, 2010.
97509: A Feasibility Study of Armodafinil for Brain Radiation-Induced Fatigue
We are pleased to open this study to all sites as of today, August 5, 2010. The protocol documents and appendices can be found at our website.
For sites outside of NC
Please make note of the required documents listed on the 97509 home page.
97405: (A Randomized Study of Soy Protein and Effexor on Vasomotor Symptoms of Men with Prostate Cancer) – This study is closed to accrual as of July 29, 2010. The IRB approval letter for this closure (amendment 11) has been posted to the website on the 97405 archived amendment page.
97106 : (A Randomized Study to Determine whether ArginMax Improves the Sexual Function and Quality of Life in Female Cancer Survivors)-The IRB approval letter for the closure of this study has been posted to thearchived amendment section of the 97106 webpage.
The adverse event (97405: AE 19) received during the month of July has been attached to this email and a summary added to theAdverse Event webpage.
In the month of July, 8 patients were accrued to CCCWFU CCOP Research Base trials. SCCC was the top accruing site with 3 patients. See the Research Base website spotlight section for further information.
Annual Meeting Registration Available - Credit Statements have been issued
Registration is now open for the Research Base 10th Annual Meeting, October 7-9, 2010 at the Hilton Wilmington Riverside in Wilmington, NC. Please use the links below to make arrangements to attend.
Register for Meeting
Continuing Education Credit
The Wake Forest University School of Medicine designates this educational activity for a maximum of 15 AMA PRA Category 1 Credit(s)TM .
Nurses, CRAs, CCRP
“This continuing nursing education activity was approved by the North Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.”
This activity has been approved for 16 contact hours
For details regarding this meeting, contact Lisa Autry Hawkins @ 336-716-0891 –email@example.com
98308: The 2010 WFU Continuing Review Approval Letter has been posted to the 98308 archived amendment page.
60A02: The 2010 WFU Continuing Review Approval Letter has been posted to the 60A02 archived amendment page.
Wake Forest University Baptist Medical Center
Department of Radiation Oncology
Research Base Protocol Information Office
2000 West First Street, Suite 401
Winston-Salem, NC 27104
Pager: 336-716-2440, ID number 1689
CONFIDENTIAL AND PRIVILEGED: The information contained in this electronic message may be privileged and confidential information intended for the sole use of the addressee and any personnel receiving a copy. If the reader of this electronic message is not the intended recipient, or the employee or agent responsible for delivering it to the intended recipient, you are hereby notified that any dissemination, distribution or copying of this communication is strictly prohibited. If you have received this electronic message in error, please notify me immediately by responding to this message.
WITHHOLD FROM PUBLIC DISCLOSURE UNDER N.C.G.S. 104E-9(a)(4)